SCHEMBL12419303

SCHEMBL12419303

CCc1cccc(B(C)C)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TP53 P04637 1/20 0.44
▸ LPL P06858 3/20 0.43
▸ LIPG Q9Y5X9 3/20 0.43
▸ ENPP2 Q13822 2/20 0.42
▸ MGLL Q99685 1/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ CYP2A6 P11509 1/20 0.40
▸ NPC1 O15118 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ BCL2 P10415 1/20 0.38
▸ RAPGEF4 Q8WZA2 1/20 0.38
▸ IDO1 P14902 1/20 0.37
▸ TRPA1 O75762 1/20 0.37
▸ KIF11 P52732 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL692342 0.80 ENPP2 (0.67) TP53LPLLIPGENPP2MGLL
SCHEMBL22562684 0.78 NOTUM (0.40) TP53LPLLIPGENPP2MGLL
SCHEMBL166894 0.77 TP53 (0.61) TP53MGLLCYP1A2CYP2A6NPC1
SCHEMBL14379304 0.77 ENPP2 (0.36) LPLLIPGENPP2MGLLALDH1A1
SCHEMBL13400376 0.77 LPL (0.40) TP53LPLLIPGENPP2MGLL
SCHEMBL13400377 0.77 LPL (0.40) TP53LPLLIPGENPP2MGLL
SCHEMBL12266159 0.75 TRPV6 (0.54) TP53LPLLIPGENPP2CYP1A2
Benzene SCHEMBL9785236 0.75 TP53 (0.67) TP53MGLLCYP1A2CYP2A6NPC1
Ammonia Solution, Strong SCHEMBL28805948 0.75 TP53 (0.58) TP53MGLLCYP1A2CYP2A6NPC1
SCHEMBL28256639 0.75 TP53 (0.58) TP53MGLLCYP1A2CYP2A6NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150368278-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE INFINITY PHARMACEUTICALS, INC. (US) 2015-12-24 — — US disclosed
US-8957049-B2 Inhibitors of fatty acid amide hydrolase INFINITY PHARMACEUTICALS, INC. (US) 2015-02-17 — — US disclosed
US-20110172186-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE INFINITY PHARMACEUTICALS, INC. 2011-07-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110172186-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE FAAH, FAAH2, ASAH1 TP53 4848/4885LPL 116/4885LIPG 258/4885
US-20150368278-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE FAAH, FAAH2, ASAH1 TP53 4848/4885LPL 116/4885LIPG 258/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback